Neurology News

For childbearing aged women with idiopathic generalized epilepsy, switching medication from valproate to levetiracetam compared with lamotrigine decreased seizure recurrence at 24 months, according to research from Neurology.

To mark this April as Parkinson’s Awareness Month, the Parkinson’s Foundation has created the #ABCsofPD to provide information about relevant symptoms, statistics and treatments.

Hypoglossal nerve stimulation reduced obstructive sleep apnea severity; however, this outcome was less likely among those with higher BMIs and those who slept in supine position, according to study results.

The risk for mental health conditions and self-harm or suicide was higher among partners and adult offspring of stroke survivors vs. the general population and family of myocardial infarction survivors, according to a study in Denmark.

A Swiss biopharmaceutical company announced its launch with $63 million in Series A financing for research and development of allosteric modulator therapeutics to address underserved neurological disorders.

The presence of a sleep disorder was associated with increased health care use in youth with chronic medical conditions, a study in the Journal of Clinical Sleep Medicine showed.

Neurocrine Biosciences Inc. announced a phase 1 study to evaluate an investigational neuropsychiatric therapy in healthy adults, as well as commencement of dosing in a phase 2 study of a novel oral compound for major depressive disorder.

“If you think it’s expensive to hire a professional to do the job, wait until you hire an amateur.”

A study identified late or varied bedtimes as risk factors for worse grades and behavioral issues among high school students, according to results published in Sleep.

A London-based biotech firm has announced a collaboration and licensing agreement with a Japanese pharmaceutical firm for discovery, development and commercialization of small activating RNA therapeutics for rare neurodegenerative diseases.